The study aims to evaluate PDK4 as a biomarker and target for immunotherapy in cancer.
Conducted multi-dimensional analysis on PDK4
Evaluated its diagnostic and prognostic capabilities
Assessed potential for personalized treatment
PDK4 shows promise as a pan-cancer biomarker
Identified as a potential target for immunotherapy
Support for personalized cancer treatment approaches
Abstract
PDK4 is a promising pan-cancer diagnostic/prognostic biomarker and potential immunotherapy target, providing a basis for personalized cancer treatment.
AI से पूछें
Like
Bookmark
Share
View Full Paper
AI से पूछें
Like
Bookmark
Share
View Full Paper
Multi-dimensional analysis reveals the potential of PDK4 as a tumor biomarker and target for immunotherapy | Synapse